Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Birth control pills can help reduce mild to moderate acne in women.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Oral contraceptives may cause significant hair loss in women.

Pro-, pre-, and synbiotics may help with PCOS, but more research is needed.

PCOS treatment combines lifestyle changes and medication to manage symptoms and improve quality of life.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Baricitinib shows promise in treating severe hair loss.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Platelet-rich plasma helps protect and improve ovarian function in rats treated with cyclophosphamide.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.